Cite
Metformin-associated prevention of weight gain in insulin-treated type 2 diabetic patients cannot be explained by decreased energy intake
MLA
UCL - SSH/ILSM - Louvain School of Management Research Institute, et al. Metformin-Associated Prevention of Weight Gain in Insulin-Treated Type 2 Diabetic Patients Cannot Be Explained by Decreased Energy Intake. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1130471970&authtype=sso&custid=ns315887.
APA
UCL - SSH/ILSM - Louvain School of Management Research Institute, Out, M., Miedema, I., Lehert, P., & 46th European Diabetes Association EASD. (2014). Metformin-associated prevention of weight gain in insulin-treated type 2 diabetic patients cannot be explained by decreased energy intake.
Chicago
UCL - SSH/ILSM - Louvain School of Management Research Institute, Mattijs Out, I. Miedema, Philippe Lehert, and 46th European Diabetes Association EASD. 2014. “Metformin-Associated Prevention of Weight Gain in Insulin-Treated Type 2 Diabetic Patients Cannot Be Explained by Decreased Energy Intake.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1130471970&authtype=sso&custid=ns315887.